ADPT

Adaptive Biotechnologies

18.08

+2.09+13.07%

After Hours: 18.07 -0.01 -0.06%16:16 06/04 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE16.00/15.99

TODAY RANGE15.96-18.13

VOL4.41M

MARKET CAP2.89B

52 WEEK RANGE9.32-20.76

AVG VOL (3M)1.93M

% TURNOVER2.76%

TURNOVER--

P/E (TTM)-55.2230

% RANGE13.52%

EPS(TTM)-0.3274

P/E(FORWARD)-38.4681

P/B13.35

BVPS1.355

DIVIDEND--

P/S10.04

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP2.83B

SHARES OUTSTANDING160.04M

NEXT EARNINGS08/03-08/07

FREE FLOAT156.68M

LOT SIZE1

EX-DATE--

News

Press Releases

Financial Reports

Profile

PUBT·6d ago
Adaptive Biotech says clonoSEQ MRD test features in 33 ASCO, EHA presentations
PUBT·05/21 20:18
Adaptive Biotech to present at William Blair Growth Stock Conference
PUBT·05/19 12:08
Artiva Biotherapeutics names Diego Miralles president, head of R&D
Seeking Alpha·05/18 10:50
Cathie Wood’s weekly update: buys Cerebras, Tempus AI, sells AMD and TSM
Dow Jones·05/12 16:31
Adaptive Biotechnologies Is Maintained at Equal-Weight by Morgan Stanley
Dow Jones·05/12 16:31
Adaptive Biotechnologies Price Target Cut to $18.00/Share From $21.00 by Morgan Stanley
TipRanks·05/12 15:26
Adaptive Biotechnologies price target lowered to $18 from $21 at Morgan Stanley
TipRanks·05/12 11:30
Analysts Offer Insights on Healthcare Companies: Neumora Therapeutics, Inc. (NMRA), Biomea Fusion (BMEA) and Adaptive Biotechnologies (ADPT)
Seeking Alpha·05/11 11:00
Cathie Wood's weekly recap: buys TEM, WGS, and CRWV; sells AMD and RKLB
TipRanks·05/07 08:14
Adaptive Biotechnologies price target lowered to $19 from $21 at JPMorgan
Dow Jones·05/06 20:27
Adaptive Biotechnologies Price Target Cut to $19.00/Share From $21.00 by JP Morgan
Dow Jones·05/06 20:27
Adaptive Biotechnologies Is Maintained at Overweight by JP Morgan
Dow Jones·05/06 18:40
Adaptive Biotechnologies Price Target Raised to $21.00/Share From $19.00 by TD Cowen
Dow Jones·05/06 18:40
Adaptive Biotechnologies Is Maintained at Buy by TD Cowen
Dow Jones·05/06 14:59
Adaptive Biotechnologies Price Target Maintained With a $21.00/Share by Guggenheim

Same Industry

Name/Symbol

Change%

Price

ADPT

REGN

GRDX

BIONTECH

BNTX

+2.69%

95.95

United Therapeutics Corp.

UTHR

-0.94%

556.82

Vertex Pharmaceuticals Inc

VRTX

-0.10%

447.54

SIGA

Moderna

MRNA

-0.80%

47.19

Charles Riv Labs Intl Inc

CRL

-0.35%

180.71

MEDP

TLPH

ICON plc

ICLR

-0.53%

136.07

CBPO

IQV

MOLECULAR PARTNERS AG

MOLN

+4.92%

4.200

ARCT

GILD

PRAH

Incyte Corp

INCY

-0.78%

96.74

Aptevo Therapeutics Inc

APVO

-1.91%

5.14

BSTC

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.